Cardiac output is a determinant of the initial concentrations of propofol after short-infusion administration

被引:118
作者
Upton, RN [1 ]
Ludbrook, GL [1 ]
Grant, C [1 ]
Martinez, AM [1 ]
机构
[1] Univ Adelaide, Royal Adelaide Hosp, Dept Anaesthesia & Intens Care, Adelaide, SA 5005, Australia
关键词
D O I
10.1097/00000539-199909000-00002
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Indicator dilution theory predicts that the first-pass pulmonary and systemic arterial concentrations of a drug will be inversely related to the cardiac output. For high-clearance drugs, these first-pass concentrations may contribute significantly to the measured arterial concentrations, which would therefore also be inversely related to cardiac output. We examined the cardiac output dependence of the initial kinetics of propofol in two separate studies using chronically instrumented sheep in which propofol (100 mg) was infused IV over 2 min. In the first study, steady-state periods of low, medium, and high cardiac output were achieved by altering carbon dioxide tension in six halothane-anesthetized sheep. The initial area under the curve and peak value of the pulmonary artery propofol concentrations were inversely related to cardiac output (R-2 = 0.57 and 0.66, respectively). For the systemic arterial concentrations, these R-2 values were 0.68 and 0.71, respectively. In our second study, transient reductions in cardiac output were achieved in five conscious sheep by administering a short infusion of metaraminol concurrently with propofol. Cardiac output was lowered by 2.2 L/min, and the area under the curve to 10 min of the arterial concentrations increased to 143% of control. Implications: The initial arterial concentrations of propofol after TV administration were shown to be inversely related to cardiac output. This implies that cardiac output may be a determinant of the induction of anesthesia with propofol.
引用
收藏
页码:545 / 552
页数:8
相关论文
共 24 条
[1]  
ALTMAYER P, 1991, METHOD FIND EXP CLIN, V13, P709
[2]   The effect of halothane on the recirculatory pharmacokinetics of physiologic markers [J].
Avram, MJ ;
Krejcie, TC ;
Neimann, CU ;
Klein, C ;
Gentry, WB ;
Shanks, CA ;
Henthorn, TK .
ANESTHESIOLOGY, 1997, 87 (06) :1381-1393
[3]   MIDAZOLAM ACTS SYNERGISTICALLY WITH FENTANYL FOR INDUCTION OF ANESTHESIA [J].
BENSHLOMO, I ;
ABDELKHALIM, H ;
EZRY, J ;
ZOHAR, S ;
TVERSKOY, M .
BRITISH JOURNAL OF ANAESTHESIA, 1990, 64 (01) :45-47
[4]  
BENUMOF JL, 1994, ANESTHESIA, P577
[5]   Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients [J].
Björkman, S ;
Wada, DR ;
Stanski, DR .
ANESTHESIOLOGY, 1998, 88 (03) :657-667
[6]  
BUHRER M, 1994, ANESTHESIOLOGY, V80, P1216
[7]   PHARMACOKINETICS AND PHARMACODYNAMICS OF THIOPENTONE - A COMPARISON BETWEEN YOUNG AND ELDERLY PATIENTS [J].
CHRISTENSEN, JH ;
ANDREASEN, F ;
JANSEN, JA .
ANAESTHESIA, 1982, 37 (04) :398-404
[8]   A PHYSIOLOGICAL MODEL FOR THE DISTRIBUTION OF INJECTED AGENTS, WITH SPECIAL REFERENCE TO PETHIDINE [J].
DAVIS, NR ;
MAPLESON, WW .
BRITISH JOURNAL OF ANAESTHESIA, 1993, 70 (03) :248-258
[9]  
FUNG HL, 1986, J PHARMACOL EXP THER, V239, P701
[10]  
Gardner MJ, 1989, STAT CONFIDENCE CONF